---
$id: https://graph.org.ai/products/commodity/51283206
$type: Product
source: UNSPSC
code: "51283206"
title: "Rokitamycin"
class: "51283200"
classTitle: "Macrolides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rokitamycin

**UNSPSC Code**: 51283206
**Class**: [Macrolides](Macrolides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a miocamycin analog and leucomycin with the molecular formula C42H69NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZPT03UEM0E, chemically known as leucomycin v, 4(sup b)-butanoate 3(sup b)-propanoate but generally known as rokitamycin, which bears US NIH Compound Identifier 5282211. European Medicines Agency schedules Rokitamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10361MIG. World Health Organization schedules rokitamycin in its Anatomical Therapeutic Chemical (ATC) Classification. ROKITAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rokitamycin under HS 29419000 and SITC 54139. As of Q4 2014, ROKITAMYCIN remains the US FDA Preferred Term for this commodity. SMILES: O(C1C(N(C)C)C(O)C(OC1C)OC1C(CC(C(O)C=CC=CCC(OC(=O)CC(O)C1OC)C)C)CC=O)C1OC(C(OC(=O)CCC)C(OC(=O)CC)(C1)C)C.

